Merck KGaA, Darmstadt, Germany, a leading science and technology company, has today announced a three-year collaboration with the research group of John Hartwig at UC Berkeley and...
Synthetic biology, like artificial intelligence (AI) machine learning, is a relatively modern field that applies emerging technologies to achieve innovation. Now scientists at Lawrence Berkeley...
Teresa Head-Gordon, Chancellor's Professor of Chemistry, Bioengineering, and Chemical and Biomolecular Engineering, joins three colleagues from Berkeley Engineering who have received funding from the C3.ai Digital Transformation Institute for COVID-19 projects.
The Molecular Sciences Software Institute has launched an open-source website that will allow biomolecular scientists from around the world to share computer-aided drug-testing simulations targeting the protein at the center of COVID-19. Under the leadership of Teresa Head-Gordon, the MolSSI team started work on the COVID-19 website about a month ago, after scores of scientists began discussing ways to share simulation modeling data they had on the coronavirus.
Researchers in the UC Berkeley lab of John Kuriyan, Chancellor's Professor at the University of California, Berkeley in the departments of Molecular and Cell Biology and Chemistry, have utilized powerful NSF funded supercomputers at the University of Texas Advanced Computing Center and the Pittsburgh Supercomputing Center to uncover the mechanism that activates cell mutations found in about 50 percent of melanomas.
Assistant Professor of Chemical and Biomolecular Engineering, Markita Landry, has been awarded a prestigious two-year DARPA Young Faculty Award for her project Brain Chemical Signaling: A New Input Signal for Brain-Computer Interfaces. Landry’s research lies at the intersection of single-molecule biophysics and nanomaterial-polymer science to develop new tools to probe and characterize complex biological systems.